SCHEMBL3355256

SCHEMBL3355256

C=CC[C@H](C(=O)OC(=O)[C@@H](CC=C)C(C)C)C(C)C

nearest known ligand 0.39

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
TSHR P16473 4/20 0.39
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
MMP1 P03956 1/20 0.35
MMP2 P08253 1/20 0.35
MMP3 P08254 1/20 0.35
MMP7 P09237 1/20 0.35
TDP1 Q9NUW8 1/20 0.34
ALDH1A1 P00352 2/20 0.32
GRIK1 P39086 2/20 0.31
GRIK2 Q13002 2/20 0.31
LMNA P02545 1/20 0.31
CYP2C19 P33261 1/20 0.31
CPA1 P15085 1/20 0.31
SLC1A3 P43003 1/20 0.30
SLC1A2 P43004 1/20 0.30
SLC1A1 P43005 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8418425 1.00 TSHR (0.39) TSHRMEN1KMT2AMMP1MMP2
SCHEMBL8422179 1.00 TSHR (0.39) TSHRMEN1KMT2AMMP1MMP2
SCHEMBL16310953 0.92 TSHR (0.34) TSHRMEN1KMT2AMMP1MMP2
SCHEMBL2336327 0.84 KMT2A (0.45) TSHRMEN1KMT2AMMP1MMP2
SCHEMBL8420441 0.84 KMT2A (0.45) TSHRMEN1KMT2AMMP1MMP2
SCHEMBL3355264 0.83 LMNA (0.40) TSHRMMP1MMP2MMP3MMP7
SCHEMBL11134509 0.83 ALDH1A1 (0.37) TSHRMEN1KMT2AMMP1MMP2
SCHEMBL4778798 0.83 TSHR (0.36) TSHRMEN1KMT2AMMP1MMP2
SCHEMBL23200430 0.79 TSHR (0.40) TSHRMEN1KMT2ATDP1ALDH1A1
SCHEMBL4798136 0.79 SLC1A3 (0.45) MMP1MMP2MMP3MMP7TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2062874-B1 Process and intermediates for the preparation of aliskiren KRKA TOVARNA ZDRAVIL D D NOVO MESTO (SI) 2014-12-17 EP disclosed
EP-2189442-B1 Process and intermediates for the preparation of aliskiren KRKA TOVARNA ZDRAVIL D D NOVO MESTO (SI) 2014-10-01 EP disclosed
EP-2189442-A1 Process and intermediates for the preparation of aliskiren Krka Tovarna Zdravil, D.D., Novo Mesto (SI) 2010-05-26 EP disclosed
EP-2062874-A1 Process and intermediates for the preparation of aliskiren KRKA, tovarna zdravil, d.d., Novo mesto (SI) 2009-05-27 EP disclosed